NewBendan (Pimobendan) is a highly effective treatment for congestive heart failure in small animals caused by dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid regurgitation). It enhances cardiac output and promotes vasodilation, improving overall cardiovascular function. Extensive clinical studies and authoritative reports have demonstrated its significant therapeutic efficacy, making it a trusted choice for managing heart failure in veterinary medicine.